Abstract
Many factors influence firms’ growth possibilities and market positions. This paper deals with business models as company’s competitiveness determinant; the case of Russian leading pharmaceutical companies is studied. The review of global pharmaceutical leaders’ business models is presented. Russian leaders are indentified basing on empirical data provided by SPARK database. It has been found that they use models of disruptive research, models aimed at business value growth as well as models of active portfolio management. Characteristics and perspectives of each model type are determined.
Original language | English |
---|---|
Pages (from-to) | 127-138 |
Number of pages | 12 |
Journal | Voprosy Ekonomiki |
Volume | 2019 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2019 |
Keywords
- Business models
- Pharmaceutical industry
- Russian leading companies
- business models
- pharmaceutical industry
OECD FOS+WOS
- 5.02.GY ECONOMICS
State classification of scientific and technological information
- 06 ECONOMY AND ECONOMIC SCIENCE